# Vogelxo(R) ABPM Study in Hypogandal Men

> **NCT04558567** · PHASE4 · COMPLETED · sponsor: **Upsher-Smith Laboratories** · enrollment: 122 (actual)

## Conditions studied

- Hypogonadism, Male

## Interventions

- **DRUG:** Vogelxo

## Key facts

- **NCT ID:** NCT04558567
- **Lead sponsor:** Upsher-Smith Laboratories
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-08-28
- **Primary completion:** 2023-12-12
- **Final completion:** 2024-01-11
- **Target enrollment:** 122 (ACTUAL)
- **Last updated:** 2024-10-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04558567

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04558567, "Vogelxo(R) ABPM Study in Hypogandal Men". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04558567. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*